Cited 3 times since 2020 (0.6 per year) source: EuropePMC Mayo Clinic proceedings, Volume 95, Issue 1, 1 1 2020, Pages 12-14 Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran. Zijlstra LE, Trompet S, Mooijaart SP, van Buren M, Jukema JW